Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

893 trials

NCT07871409
Recruiting
Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight
Phase 3 · Puerto Rico, United States · 25 sites
Registry update: 9 Nov 2026
2025-523374-17-03
Recruiting
Insulin resistance in type 2 diabetes: evaluating the pathogenic mechanisms of insulin resistance in the myocardium and the effects of the treatments with GLP-1RA and SGLT2i
Phase 4 · Spain · 1 site
Registry update: 19 Jun 2026
NCT07900438
Recruiting
A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China
Phase 4 · China · 26 sites
Registry update: 28 Oct 2026
2026-525932-40-00
Recruiting
An Open-Label, Controlled, Multiple-Dose Phase I Clinical Trial Evaluating the Steady-State Pharmacokinetics, Pharmacodynamics and Safety of SHR-3167 in Subjects With Type 2 Diabetes
Phase 1 · Germany · 1 site
Registry update: 18 Sept 2026
NCT07409714
Recruiting
SMART 2D: Study of Montelukast's Effects on Renal and Cardiovascular Health in Adolescents and Young Adults With Type 2 Diabetes
Early phase 1 · United States · 1 site
Registry update: 6 Oct 2026
NCT07868601
Recruiting
LIfestyle MEtabotype Study A
Not applicable · Germany · 1 site
Registry update: 9 Oct 2026
NCT07843485
Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes
Phase 3 · Czechia, Hungary, Poland, United States · 18 sites
Registry update: 5 Nov 2026
NCT07868354
Recruiting
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication
Phase 1 · United States · 2 sites
Registry update: 16 Oct 2026
NCT07633171
Recruiting
Multimodal Glucose Prediction in Type 2 Diabetes
Not applicable · United States · 1 site
Registry update: 8 Oct 2026
2026-526336-39-00
Recruiting
Efficacy and Safety of Once-Daily Oral ASC30 Compared with Placebo in Participants with Obesity or Overweight with Type 2 Diabetes Mellitus
Phase 3 · Czechia, Germany, Greece, Poland · 43 sites
Registry update: 13 Oct 2026
NCT07864168
Recruiting
Evaluation of MiniMed Next Generation Extended Wear Sensors and Algorithm in Patients With Type 1 and Type 2 Diabetes
Not applicable · United States · 17 sites
Registry update: 20 Oct 2026
NCT07855133
Recruiting
A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication
Phase 1 · United States · 2 sites
Registry update: 16 Oct 2026
NCT07575438
Recruiting
Effects of Different Fish Oil Types on Type 2 Diabetes Risk Factors in High-Risk Adults
Phase 2 · Canada · 1 site
Registry update: 8 Oct 2026
2025-522698-13-00
Recruiting
Evaluation of Influenza Vaccine Immune Response in Obesity (VaccObFlu)
Phase 4 · Sweden · 1 site
Registry update: 8 Jul 2026
NCT07829302
Recruiting
VV-14299 and VV-14300 for the Treatment of Type 1 Diabetes
Phase 1/2 · Australia · 1 site
Registry update: 5 Oct 2026
NCT07792226
Recruiting
ENLIGHT Trial: ESG With Fundal Mucosal Ablation
Not applicable · United States · 1 site
Registry update: 19 Oct 2026
NCT07831798
Recruiting
VV-14300 for the Treatment of Type 1 Diabetes
Phase 1/2 · Canada, New Zealand · 2 sites
Registry update: 5 Oct 2026
NCT07912944
Recruiting
Lifestyle Medicine for Type 2 Diabetes Remission in Pakistan
Not applicable · Pakistan · 2 sites
Registry update: 3 Nov 2026
NCT07641361
Recruiting
Hydration Intervention to Decrease Side Effects Associated With GLP - 1 RA Therapy
Not applicable · United States · 1 site
Registry update: 2 Oct 2026
NCT06375460
Recruiting
Real-time Engagement for Learning to Effectively Control Type 2 Diabetes
Not applicable · United States · 1 site
Registry update: 7 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.